Clinical trial participants: no more study subject, but research partners

Oct 28, 2024 | News

At the Clinical Research As A Care Option (CRAACO) Conference held in Philadelphia on September 16-18, 2024, Nadir Ammour, Global Lead, Clinical Innovation & External Partnerships, Sanofi and co-leader of the FACILITATE project, was the guest speaker in the panel Returning Participant’s Individual Clinical trial Data.

Ammour began his speech by capturing the attention of the audience with the definition of ‘Patient-Centered Research’ as the active, meaningful, and collaborative interaction between patients and researchers at all stages of the research process, where research decision-making is guided by the contribution of patients as partners, recognizing their specific experiences, values, and expertise.

Patient centricity” stated Ammour “is the commitment to listen and translate patient insights into actions that develop new healthcare solutions with meaningful outcomes, address unmet needs and improve health-related quality of life”.

In terms of shaping research and development programs, patient experience and preference inform benefit risk, identifies outcomes that matter most and support recruitment.

Building on this consideration, Ammour emphasized that clinical trial participants should not be considered “Study subjects” but true “Research partners”.

FACILITATE expected to assist both private and public researchers in navigating the ethical, legal, and science integrity, complexities associated with returning individual clinical trial data to participants.

The European project intends to deliver recommendations and proposed processes so that study participants can access their data in a manner that is both meaningful and respectful of their autonomy. Among its main goals:

  • to develop guidelines for processing and returning study participants data,
  • to propose those guidelines with ethical committees and data protection authorities,
  • to enhance patient willingness to be involved and participate,
  • to inform changes to regulation(s) If needed.

“What is fundamental today” said Ammour in conclusion of his speech “is to emphasize the importance of ongoing dialogue and research in this area and encourage attendees to consider how they can contribute to this important aspect of patient care in their own work”.

Recent news

Save the date! – Let’s FACILITATE Webinar 2025

Save the date! – Let’s FACILITATE Webinar 2025

On June 25, 2025 join us and participate in the FACILITATE public webinar! The event will feature a stakeholders virtual roundtable, where we aim to explore the FACILITATE work on the Return of Individual Participant Data (RoIPD). Alongside patient testimonials, we...

read more
Join Us for the European Patients’ Rights Day 2025!

Join Us for the European Patients’ Rights Day 2025!

Exploring the benefits of health data sharing for patients, healthcare systems, and medical research at the EU level 15 May 2025 | European Parliament, Brussels (Belgium) 📅 Date: 15 May 2025📍 Location: Room A3H1 | European Parliament, Brussels🎟 Register here now...

read more
Access, reuse and sharing health data

Access, reuse and sharing health data

To ensure that Ireland can benefit from data driven research, on 28 March 2025 the Royal College of Surgeons in Ireland (RCSI) convened a one-day conference’s to co-create practical, sustainable solutions that can support responsible and timely data use. This...

read more
Demystifying The EU Health Data Space

Demystifying The EU Health Data Space

On 3 February 2025, Luca Pani, FACILITATE coordinator, delivered a comprehensive keynote presentation at the two-day Clinical Research Data Sharing Alliance-CRDSA’s 2025 Summit, exploring the challenges and opportunities of the European Health Data Space (EHDS). His...

read more

Join our POOL OF STAKEHOLDERS!

Do you want to receive our updates, access information on our activities and events and be in contact with our project?

Latest News

Upcoming Events

Report